Duodenal Clinical Trials

1 recruitingLast updated: May 5, 2026

There are 28 actively recruiting duodenal clinical trials across 20 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3. Top locations include Fort Wayne, Indiana, United States, Minya, Minya Governorate, Egypt, Bucharest, Romania. Updated daily from ClinicalTrials.gov.


Duodenal Trials at a Glance

28 actively recruiting trials for duodenal are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Fort Wayne, Minya, and Bucharest. Lead sponsors running duodenal studies include Minia University, Ankara City Hospital Bilkent, and AdventHealth.

Browse duodenal trials by phase

Treatments under study

About Duodenal Clinical Trials

Looking for clinical trials for Duodenal? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Duodenal trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Duodenal clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 28 trials

Recruiting

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+9 more
Seattle Children's Hospital200 enrolled1 locationNCT06315179
Recruiting
Phase 4

Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP

SedationERCPDuodenal Spasm
Ankara City Hospital Bilkent120 enrolled1 locationNCT07333859
Recruiting
Phase 2

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Esophageal AdenocarcinomaGastric AdenocarcinomaPancreas Adenocarcinoma+6 more
Yale University54 enrolled1 locationNCT07282912
Recruiting
Not Applicable

Haemostatic Gel Prophylaxis for Post Duodenal Endoscopic Resection Bleeding

Duodenal Bleeding
GCS Ramsay Santé pour l'Enseignement et la Recherche234 enrolled1 locationNCT05746884
Recruiting
Phase 1

Study of SGR-1505 in Mature B-Cell Neoplasms

High-grade B-cell LymphomaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+23 more
Schrödinger, Inc.98 enrolled36 locationsNCT05544019
Recruiting
Phase 2

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Pancreatic NeoplasmDuodenal Neoplasm
Masonic Cancer Center, University of Minnesota78 enrolled1 locationNCT06411795
Recruiting

Integrated Cancer Repository for Cancer Research

Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled45 locationsNCT02012699
Recruiting
Not Applicable

Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy

Pancreatic Ductal AdenocarcinomaPancreatic Neuroendocrine TumorAmpullary Carcinoma+2 more
Minia University90 enrolled1 locationNCT07328607
Recruiting
Phase 4

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Neuro Endocrine TumoursPDAC - Pancreatic Ductal AdenocarcinomaPancreas Adenocarcinoma+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)400 enrolled1 locationNCT07262957
Recruiting

Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip

FistulaPerforated BowelGI Bleeding+3 more
AdventHealth250 enrolled2 locationsNCT05852457
Recruiting

Endoscopic Resection of Gastrointestinal Neoplasms

Esophageal NeoplasmsColonic NeoplasmsEndoscopic Mucosal Resection+3 more
Azienda USL Reggio Emilia - IRCCS2,000 enrolled1 locationNCT04780256
Recruiting

Duodenal Polyposis Classification in FAP

Familial Adenomatous PolyposisFAPDuodenal Neoplasms+6 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano300 enrolled2 locationsNCT07199127
Recruiting
Phase 3

Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas

Pancreatic CancerCholangiocarcinomaPancreatic Ductal Adenocarcinoma+4 more
Minia University194 enrolled1 locationNCT07155525
Recruiting

Prevention of Postoperative Hernias in Emergency Surgery

IleusAppendicitis AcuteCholecystitis, Acute+3 more
Jan Kochanowski University500 enrolled1 locationNCT06815822
Recruiting
Not Applicable

To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy (Age ≥ 18 Years, Informed Consent), Between Total Inspection Time Versus Withdrawal Time, for the Identification of Malignant Lesions

GastricPremalignant ConditionsMalignant Lesions+2 more
Portuguese Oncology Institute, Coimbra1,290 enrolled1 locationNCT06696209
Recruiting
Not Applicable

High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery

CholangiocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Adenocarcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University845 enrolled2 locationsNCT02757859
Recruiting
Not Applicable

Double Pig Tail Stent-assisted Fixation of Fully Covered Metal Stents for the Treatment of Benign Duodenal Strictures

Benign Duodenal Stricture
Shupei Li5 enrolled1 locationNCT06736301
Recruiting

Endoscopic Submucosal Dissection Registry

Neoplasm, ColorectalNeoplasm, StomachNeoplasm, Esophagus+1 more
Carol Davila University of Medicine and Pharmacy200 enrolled1 locationNCT06033976
Recruiting
Not Applicable

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

Pancreas CancerPancreas AdenocarcinomaPancreaticoduodenal Lymphadenopathy
Humanitas Hospital, Italy180 enrolled1 locationNCT04571294
Recruiting
Not Applicable

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Follicular Lymphoma (Gastric or Duodenal)Marginal Zone Lymphoma (Gastric or Duodenal)
University Hospital Muenster83 enrolled1 locationNCT04097067